Earlier this week, Walgreens Boots Alliance (Nasdaq: WBA) CEO Tim Wentworth teased a “strategic review” of the company’s assets, including those within the U.S. Healthcare segment. Meanwhile, CVS Health (NYSE: CVS) CFO Tom Cowhey provided updates on where Aetna may go with its supplemental benefits in the near-term future.  “We are now meaningfully looking at […] The post While Walgreens Conducts Strategic Review Of Assets, CVS Health Considers Supplemental Benefit Cuts In MA appeared first on Home Health Care News.

View Entire Post